33A-11740-64568
4 vaccinations
5 coded responses
23 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 481 / MI
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Registered in v-safe
-
2021-01-19
Dose 1 — Pfizer-BioNTech
- 2021-01-19
- 2021-01-20
- 2021-01-22
- 2021-01-23
- 2021-01-24
-
2021-01-25
Survey response — days 1–6 daily, dose 1MedDRA: Oral herpes — Feeling: GoodFree text: Cold sore on lipMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
-
2021-02-02
Survey response — day 14, dose 1MedDRA: Fatigue, Headache, Oropharyngeal pain — Feeling: GoodFree text: Sore throatFatigueHeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Dose 2 — Pfizer-BioNTech
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
-
2021-05-11
Survey response — 3 months, dose 2MedDRA: Fatigue, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Runny nose, sore throat, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-10
-
2021-12-03
Dose 3 — Pfizer-BioNTech
- 2022-02-09
-
2022-09-27
Dose 4 — Pfizer-BioNTech
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-25
-
2022-12-27
Survey response — 3 months, dose 4MedDRA: Pregnancy — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Pregnancy related hyperemesisMedDRA releases: 2024-11 · check-in free text available
-
2022-12-27
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-28
Call successfulNot applicable - Accidental Reporting
-
2023-03-29
Survey response — 6 months, dose 4MedDRA: Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech | |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
| 4 | 2022-09-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-27 | Successful 2022-12-28 |
Not applicable - Accidental Reporting |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Cold sore on lip
Release 3 — day 14, dose 1
Symptoms: Sore throatFatigueHeadache
Release 8 — 3 months, dose 2
Symptoms: Runny nose, sore throat, fatigue
Release 12 — 3 months, dose 4
Symptoms: Pregnancy related hyperemesis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Oral herpes | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release